Organon & Co (OGN)
19.51
+0.68
(+3.61%)
USD |
NYSE |
May 02, 16:00
19.51
0.00 (0.00%)
After-Hours: 20:00
Organon Cash and Short Term Investments (Quarterly): 693.00M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 693.00M |
| September 30, 2023 | 414.00M |
| June 30, 2023 | 326.00M |
| March 31, 2023 | 459.00M |
| December 31, 2022 | 706.00M |
| September 30, 2022 | 499.00M |
| June 30, 2022 | 545.00M |
| Date | Value |
|---|---|
| March 31, 2022 | 694.00M |
| December 31, 2021 | 737.00M |
| September 30, 2021 | 1.008B |
| June 30, 2021 | 730.00M |
| March 31, 2021 | 141.00M |
| December 31, 2020 | 12.00M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
12.00M
Minimum
Dec 2020
1.008B
Maximum
Sep 2021
535.69M
Average
545.00M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Merck & Co Inc | 7.093B |
| Alnylam Pharmaceuticals Inc | 2.439B |
| Amgen Inc | 10.94B |
| Biogen Inc | 1.074B |
| Pacira BioSciences Inc | 278.58M |